OATD-02
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for OATD-02, covering 2025-02-24 to 2025-02-24. Get the full timeline:
Most recent: Clinical Trial Update: First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients with Selected Advanced And/or Metastatic Solid Tumours [Phase 1]